anti-Ly49C,F,H,I antibody product blog
Tags: Antibody; Monoclonal Antibody; Ly49C,F,H,I; anti-Ly49C,F,H,I antibody;
The Ly49C,F,H,I n/a (Catalog #MBS604172) is an Antibody produced from Hamster and is intended for research purposes only. The product is available for immediate purchase. The Ly49C,F,H,I (Biotin) reacts with Mouse and may cross-react with other species as described in the data sheet. MyBioSource\'s Ly49C,F,H,I can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS).Flow cytometry 1
Dilution: Flow Cytometry: 1ug/10e6 cells. Researchers should empirically determine the suitability of the Ly49C,F,H,I n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse Ly49 receptors exhibit allelic specificity for MHC class I Ia molecules and are thought to serve to prevent natural killer (NK) cells from attacking normal cells, while allowing them to attack infected or transformed cells in which class I molecules have been down-regulated.2 These inhibitory receptors are also expressed on a subpopulation of mouse CD8+ T cells. The antibody stains ~ 90% of NK1.1+CD3- splenocytes, and ~ 6% of CD8+ spleen cells from C57BL/6 mice.1 The antibody also stains 30-80% of NK1.1+CD3- splenocytes in other mouse strains tested (BALB/c, C3H, 129, SJL, AKR/J).
In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Ly49C,F,H,I are readily searchable from our website. Different antibodies against the same target such as Ly49C,F,H,I may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.